Physician profile
Mark Tomsho
NPI 1326016783
$731.46
in general payments reported to CMS, 2019-2025
8 companies · $21.47 in 2025
The $21.47 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.87 · 2020: $11.16 · 2021: $182 · 2022: $178 · 2023: $144 · 2024: $97.04 · 2025: $21.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $220.46 | 2022-2024 | Azstarys |
| Glaxosmithkline, LLC. | $216.52 | 2019-2024 | Pediarix, Bexsero, Rotarix |
| Takeda Pharmaceuticals U.S.A., INC. | $110.71 | 2021 | |
| Ironshore Pharmaceuticals INC. | $78.15 | 2019-2023 | Jornay Pm |
| Pfizer INC. | $34.49 | 2023-2025 | |
| Greenwich Biosciences, INC. | $30.48 | 2019 | |
| Biogen, INC. | $21.95 | 2021 | |
| Kyowa Kirin, INC. | $18.70 | 2024 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Tomsho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.